Related Experiment Video
Updated: Jul 15, 2026

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
Published on: June 16, 2008
Pervasive HIV recombination limits the utility of circulating recombinant form nomenclature
Heather E Grant1, Abayomi S Olabode2, Dorothea Seiler Vellame3
1Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, United Kingdom.
Insights
The current naming of HIV-1 circulating recombinant forms (CRFs) is biologically unjustified. Prioritizing taxonomically meaningful clades with significant epidemiological spread is crucial for understanding HIV-1 diversity.
Area of Science:
- Virology
- Epidemiology
- Genetics
Background:
- Human Immunodeficiency Virus type 1 (HIV-1) diversity is tracked using designations like subtypes, groups, and circulating recombinant forms (CRFs).
- CRFs are descendent viruses from intersubtype recombination events.
Purpose of the Study:
- To argue against designating all detected CRFs as distinct entities due to limited biological and epidemiological significance.
- To propose a shift towards prioritizing taxonomically meaningful clades based on biological significance.
Main Methods:
- The study critically evaluates the current methodology for naming HIV-1 CRFs.
- It examines the mechanistic underpinnings of HIV-1 recombination and its implications for classification.
Main Results:
- Many designated CRFs represent recombinants with limited epidemiological significance.
- The majority of incidentally named recombinants are rarely detected again, highlighting the arbitrary nature of current naming conventions.
Conclusions:
- Continuing to designate all detected CRFs as distinct entities is biologically unjustified.
- Prioritizing clades with demonstrable biological significance (e.g., epidemiological spread, phenotypic properties, transmission advantage) is essential for meaningful HIV-1 diversity tracking.
Abstract:
The naming of HIV-1 circulating recombinant forms (CRFs)-descendent viruses from the same intersubtype recombination events, is along with the designation of 'subtypes' and 'groups', routinely used to track HIV-1 diversity. However, we argue that continuing to designate all detected CRFs as distinct entities is biologically unjustified, as many represent recombinants of limited epidemiological significance. Indeed, the mechanistic underpinning of HIV-1 recombination highlights the arbitrary nature of naming these incidental recombinants, the majority of which are rarely detected again. This underlines the need to prioritise taxonomically meaningful clades, with a focus on biological significance such as emergence events associated with significant epidemiological spread, phenotypic properties or transmission advantage.
Related Concept Videos
Viral Recombination
Retrovirus Life Cycles
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Size and Structure of Viral Genomes
Recombinant DNA
